Umeå universitets logga

umu.sePublikationer
Driftinformation
Ett driftavbrott i samband med versionsuppdatering är planerat till 17/11-2026, kl 12.00-13.00. Under den tidsperioden kommer DiVA inte att vara tillgängligt.
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Outcomes of iStent inject versus kahook dual blade surgery in glaucoma patients undergoing cataract surgery
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk vetenskap, Oftalmiatrik.ORCID-id: 0000-0001-6025-2523
Division of Ophthalmology and Vision, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Ophthalmology, Capio Sophiahemmet Hospital, Stockholm, Sweden.
Umeå universitet, Medicinska fakulteten, Wallenberg centrum för molekylär medicin vid Umeå universitet (WCMM). Umeå universitet, Medicinska fakulteten, Institutionen för klinisk vetenskap, Oftalmiatrik. Department of Ophthalmology, University of Iceland, Reykjavik, Iceland.ORCID-id: 0000-0003-0218-4563
2023 (Engelska)Ingår i: Journal of glaucoma, ISSN 1057-0829, E-ISSN 1536-481X, Vol. 32, nr 10, s. e121-e128Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Précis: iStent Inject implantation (iStent) or Kahook Dual Blade goniotomy (KDB) in combination with phacoemulsification have a similar IOP-lowering effect in all stages of glaucoma, and medications are significantly reduced, especially after KDB.

PURPOSE: To compare the 2-year efficacy and safety of iStent or KDB in combination with phacoemulsification in eyes with mild to advanced open angle glaucoma.

METHODS: A retrospective chart review of 153 patients that received iStent or KDB in combination with phacoemulsification at a single center between March 2019 and August 2020. The main outcome parameters at 2 years were: (1) intraocular pressure (IOP)-reduction ≥20%, with a postoperative IOP ≤18 mm Hg, and (2) a reduction of ≥1 medication. Results were stratified by glaucoma grade.

RESULTS: After 2 years, mean IOP was reduced from 20.3±6.1 to 14.2±4.1 mm Hg in the phaco-iStent group ( P <0.001) and from 20.1±6.1 to 14.7±3.6 mm Hg in the phaco-KDB group ( P <0.001). The mean number of medications was reduced from 3.0±0.9 to 2.6±1.1 in the Phaco-iStent group ( P =0.001) and from 2.3±1.0 to 1.5±1.3 in the Phaco-KDB group ( P <0.001). Success regarding IOP-reduction ≥20% with a postoperative IOP ≤18 mm Hg was met by 46% in the phaco-iStent group and by 51% in the phaco-KDB group. A reduction of ≥1 medication was met by 32% in the phaco-iStent group and by 53% in the phaco-KDB group ( P =0.013). Eyes with mild to moderate and advanced glaucoma responded equally well to the success criteria.

CONCLUSIONS: iStent and KDB, in combination with phacoemulsification, both lowered IOP effectively in all stages of glaucoma. More medications were reduced after KDB, suggesting that it may be a more effective procedure compared with iStent.

Ort, förlag, år, upplaga, sidor
Wolters Kluwer, 2023. Vol. 32, nr 10, s. e121-e128
Nationell ämneskategori
Oftalmologi
Identifikatorer
URN: urn:nbn:se:umu:diva-215079DOI: 10.1097/IJG.0000000000002243ISI: 001077170100002PubMedID: 37327470Scopus ID: 2-s2.0-85172940680OAI: oai:DiVA.org:umu-215079DiVA, id: diva2:1804670
Forskningsfinansiär
Region Jämtland HärjedalenRegion VästerbottenKnut och Alice Wallenbergs StiftelseTillgänglig från: 2023-10-13 Skapad: 2023-10-13 Senast uppdaterad: 2026-01-12Bibliografiskt granskad
Ingår i avhandling
1. Microinvasive trabecular surgery in glaucoma
Öppna denna publikation i ny flik eller fönster >>Microinvasive trabecular surgery in glaucoma
2026 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Alternativ titel[sv]
Mikroinvasiv trabekulär kirurgi vid glaukom
Abstract [en]

To manage the increasing prevalence of glaucoma, we need access to effective and safe medical and surgical treatments that can lower the intraocular pressure (IOP) – so far the only proven strategy to slow disease progression. Treatment typically starts with eye drops or a laser procedure, but many patients will eventually require surgery. Traditional surgery is time-consuming and carries significant risks, whereas microinvasive glaucoma surgery (MIGS) has emerged as a safer, earlier option that could potentially prevent or delay more invasive procedures such as a trabeculectomy. Additionally, many patients with glaucoma develop cataract, and MIGS procedures can be conveniently performed together with the cataract operation. Although MIGS is now widely adopted, concerns about bias remain as many studies are industry-funded. The benefit of combining MIGS with cataract surgery is also debated, especially in advanced glaucoma. Moreover, research is scarce for pseudoexfoliation glaucoma (PEXG), common in the Nordic countries and harder to treat, with a poorer prognosis than other open-angle glaucoma types.

In this thesis, we evaluate the efficacy and safety of the trabecular MIGS procedures iStent inject® (iStent) and Kahook Dual Blade® (KDB) across various stages and subtypes of glaucoma. We show that KDB is effective and safe when combined with cataract surgery, whereas its efficacy as a stand-alone procedure is lower. Therefore, we do not recommend the stand-alone approach in patients with advanced or uncontrolled glaucoma.

Furthermore, iStent and KDB demonstrate comparable outcomes, showing effectiveness not only in mild to moderate disease but also in advanced stages and in PEXG. Our results show that trabecular MIGS combined with cataract surgery is effective even in patients with markedly elevated IOP and/or on maximum tolerated therapy. These patients, previously considered candidates for bleb-forming surgery, may instead begin with trabecular MIGS combined with cataract surgery. Many patients undergoing trabecular surgery have previously received laser trabeculoplasty (LTP), and we show that LTP does not seem to negatively affect the surgical outcomes of cataract surgery combined with KDB.

Finally, surgical success can be enhanced if iStent or KDB is added to the cataract operation, and in stable glaucoma patients this will mainly be due to greater medication reductions. Postoperative IOP spikes can also be reduced by more than half by adding iStent or KDB.

In summary, this thesis demonstrates that trabecular MIGS as a stand-alone procedure offered only moderate success and often required further interventions. Therefore, we do not recommend the stand-alone approach in patients with advanced or uncontrolled glaucoma. When performed together with cataract surgery, our data show that trabecular MIGS is both effective and safe – even in patients with markedly elevated IOP and/or on maximum tolerated therapy. In more stable glaucoma patients with lower preoperative IOP levels and a low rate of progression, combining trabecular MIGS with cataract surgery can be considered when medication reduction is a clinical goal. This approach also lowers the risk of early IOP spikes, and both iStent and KDB perform equally well, with comparable outcomes in PEX and non-PEX eyes.

Ort, förlag, år, upplaga, sidor
Umeå: Umeå University, 2026. s. 101
Serie
Umeå University medical dissertations, ISSN 0346-6612 ; 2394
Nyckelord
MIGS, glaucoma surgery, cataract surgery, iStent inject, Kahook Dual Blade
Nationell ämneskategori
Oftalmologi
Identifikatorer
urn:nbn:se:umu:diva-248491 (URN)978-91-8070-846-3 (ISBN)978-91-8070-845-6 (ISBN)
Disputation
2026-02-06, Hörsalen Östersunds sjukhus, Östersund, 09:00 (Engelska)
Opponent
Handledare
Anmärkning

Löpnummer och ISSN för serien "Umeå University medical dissertations" (ISSN 0346-6612) saknas i fulltexten.

Tillgänglig från: 2026-01-16 Skapad: 2026-01-12 Senast uppdaterad: 2026-01-15Bibliografiskt granskad

Open Access i DiVA

fulltext(348 kB)318 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 348 kBChecksumma SHA-512
cb0504bed5fa0ed3e274803ba29a2807118e195c6a360e2849bf1011a90c9d9e7dbbd8c1389704bf05bf11cc2c776ef7718721b6f701495a351383e61f47ac7e
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Barkander, AnnaJóhannesson, Gauti

Sök vidare i DiVA

Av författaren/redaktören
Barkander, AnnaJóhannesson, Gauti
Av organisationen
OftalmiatrikWallenberg centrum för molekylär medicin vid Umeå universitet (WCMM)
I samma tidskrift
Journal of glaucoma
Oftalmologi

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 319 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 898 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf